实验室运营商奎斯特诊疗(DGX)今日股价盘中大涨5.07%,引发市场关注。消息显示,该公司刚刚公布的2024年第三季度业绩超出华尔街预期,推动股价走高。
根据最新财报数据,奎斯特诊疗第三季度营收达24.9亿美元,高于市场预期的24.2亿美元;每股收益为2.30美元,同样超过了分析师此前预期的2.26美元。业绩表现优于预期,主要得益于诊断测试服务需求强劲。
最近几个季度,随着更多人,特别是老年人补上了疫情期间推迟的手术等,对诊断检查的需求有所增加。借此东风,奎斯特诊疗业绩实现了同比大幅增长。同时公司对全年营收展望也进行了上调,体现了其对未来业务的乐观预期。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.